Ausgewählte Studien

Ixekizumab im Vergleich zu Fumarsäureestern und Methotrexat bei der Behandlung der Nagelpsoriasis bei Patienten mit mittelschwerer bis schwerer …Den ganzen Artikel lesen

J Dtsch Dermatol Ges. 2024 Feb;22(2):278-281. doi: 10.1111/ddg.15292. Epub 2024 Jan 7. NO ABSTRACT PMID:38185772 | DOI:10.1111/ddg.15292 Den ganzen Artikel lesen

Ixekizumab versus FAEs and methotrexate in treatment of nail psoriasis in patients with moderate-to-severe psoriasisDen ganzen Artikel lesen

Dermatologie (Heidelb). 2023 Dec 15. doi: 10.1007/s00105-023-05253-z. Online ahead of print. ABSTRACT Janus kinase inhibitors (JAKi) represent an immunomodulatory targeted therapy in various dermatoses. Throughout the past few years, JAKi have been approved for atopic dermatitis (AD), psoriasis vulgaris (PSO), alopecia areata (AA), and vitiligo. Further indications are currently under investigation. In this article the various systenic and topical JAKi used in dermatology are being presented reg

Klin Monbl Augenheilkd. 2022 May;239(5):695-701. doi: 10.1055/a-1741-8104. Epub 2022 Apr 14. ABSTRACT A large proportion of patients with visual impairment secondary to non-infectious uveitis may require DMARDs. Although these are highly effective, some patients may require alternatives to the currently available immunomodulators due to an inadequate response or undesirable side effects. Janus Kinase Inhibitors (JAKi) are already approved for several autoimmune diseases in rheumatology, gastroen

Pre-clinical and clinical evidence for suppression of alcohol intake by apremilast 1Department of Behavioral Neuroscience, Oregon Health & Science …Den ganzen Artikel lesen

N. F. T. Henckens, Corresponding Author N. F. T. Henckens [email protected] Department of Dermatology, Radboud University Medical Centre (Radboudumc), …Den ganzen Artikel lesen

Although stress is considered to be a negative factor for psoriasis, no convincing scientific evidence of this association exists, largely because of …Den ganzen Artikel lesen

Andrea Chiricozzi, Corresponding Author Andrea Chiricozzi [email protected] Dermatologia, Dipartimento Universitario di Medicina e Chirurgia …Den ganzen Artikel lesen

T. Torres, Corresponding Author T. Torres [email protected] Department of Dermatology, Centro Hospitalar Universitário de Santo António, Porto, …Den ganzen Artikel lesen

Shir Azrielant, Corresponding Author Shir Azrielant [email protected] St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, …Den ganzen Artikel lesen

People with skin disease suffer due to disease-related physical symptoms, as well as due to significant psychosocial burden. A major contributor of …Den ganzen Artikel lesen

T. Torres, Corresponding Author T. Torres [email protected] Department of Dermatology, Centro Hospitalar Universitário de Santo António, Porto, …Den ganzen Artikel lesen

Dermatological research has traditionally concentrated on evaluating mental comorbidities, neglecting positive concepts like happiness. Initial …Den ganzen Artikel lesen

Dear Editor, Psoriasis onset in women often overlaps with the peak reproductive age (18 and 45 years).1 This presents unique challenges in the …Den ganzen Artikel lesen

Ravelli A, Consolaro A, Schiappapietra B, Martini A. Ravelli A, et al. Clin Exp Rheumatol. 2015 Sep-Oct;33(5 Suppl 93):S40-3. Epub 2015 Oct 15. Clin …Den ganzen Artikel lesen

Arthritis Rheumatol. 2022 Jul 29. doi: 10.1002/art.42315. Online ahead of print. ABSTRACT OBJECTIVE: To analyse the prevalence of spondyloarthritis (SpA) in patients with acute anterior uveitis (AAU), to identify parameters associated with SpA presence, and to evaluate referral algorithms. METHODS: Prospectively recruited consecutive patients with non-infectious AAU underwent structured rheumatologic assessment including magnetic resonance imaging of sacroiliac joints allowing a definitive diagn

J Dtsch Dermatol Ges. 2023 May;21(5):473-481. doi: 10.1111/ddg.15007_g. ABSTRACT HINTERGRUND UND ZIELE: Die steigende Anwendung von Biologika bei der Behandlung entzündlicher Erkrankungen hat zu mehr Leishmaniose-Fällen bei Patienten mit iatrogener Immunsuppression geführt. Vorrangiges Ziel war die Beschreibung der Charakteristika von Patienten mit kutaner (CL) oder mukokutaner (MCL) Leishmaniose, die zum Zeitpunkt der Diagnose mit Biologika behandelt wurden. PATIENTEN UND METHODEN: Mit Kohorte

Z Rheumatol. 2021 Dec 23. doi: 10.1007/s00393-021-01139-4. Online ahead of print. ABSTRACT Since 2001 rheumatologists throughout Germany have been recruiting patients with rheumatoid arthritis into the biologics register (rheumatoid arthritis: observation of biologics treatment, RABBIT) to investigate the long-term safety and efficacy of modern antirheumatic treatment. Over the past 20 years more than 20,000 patients have been enrolled in the prospective cohort study. This article summarizes the

Journal of the European Academy of Dermatology and Venereology Volume 37, Issue S7 p. 15-16 Open Access Matthias Augustin, Corresponding Author Matthias …Den ganzen Artikel lesen

ORIGINAL ARTICLE Line-field confocal optical coherence tomography: new insights for psoriasis treatment monitoring C. Orsini Dermatology Unit, …Den ganzen Artikel lesen

Psoriasis vulgaris is a systemic, chronic inflammatory disease affecting 2–3% of the population. Recent advances in the understanding of the pathophyDen ganzen Artikel lesen

Full text linksCite Display options Display options Introduction: Tumour necrosis factor inhibitor (TNFi) agents are most often the first-choice …Den ganzen Artikel lesen

Mital R, Gray A, Minta A, Almhana F, Amin S, Hydol-Smith J, Mallela T, Kaffenberger BH. Mital R, et al. Dermatol Ther (Heidelb). 2023 …Den ganzen Artikel lesen

J Eur Acad Dermatol Venereol. 2021 May 31. doi: 10.1111/jdv.17427. Online ahead of print. ABSTRACT In the context of the current coronavirus disease 2019 (COVID-19) pandemic, there is no direct evidence to support any preferred biologic therapy for psoriasis. However, known safety profile of different classes of biologic therapies as well as individual risk factors for infections must be considered. Here, we report incidence rates of respiratory or viral infections through 5 years among patients